This article is more than 5 years old. Information may no longer be current.
Stryker names Bruder vice president, chief medical and scientific officer
Click Here to Manage Email Alerts
Stryker Corporation has announced that Scott P. Bruder, MD, PhD, has joined the company in the newly created position of vice president, chief medical and scientific officer. He will oversee the clinical and scientific efforts of Stryker and represent the company as the leading medical authority of the company for trade associations, regulatory bodies and other entities while also partnering with teams across the organization.
"We are excited that Scott will be joining our executive leadership team and further broadening our clinical and scientific expertise while also strengthening our capabilities in the critical areas of evidence-based medicine,” Kevin A. Lobo, president and chief executive officer of Stryker, stated in a company press release.
According to the release, Bruder worked at Becton, Dickinson and Company for the past 5 years as the chief science and technology officer, where he was responsible for identifying and cultivating new growth opportunities, improving the product development system and enhancing global research capabilities. He also spent 8 years at Johnson & Johnson in a series of senior executive and scientific roles in various businesses, and held leadership roles at Anika Therapeutics and Osiris Therapeutics.
Bruder has more than 20 issued and pending patents, nearly 150 publications and numerous honors from the American Academy of Orthopaedic Surgeons, the Orthopaedic Research Society and the Association of Bone and Joint Surgeons.